Welcome to LookChem.com Sign In|Join Free

CAS

  • or
D-Alaninamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

35320-22-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 35320-22-0 Structure
  • Basic information

    1. Product Name: D-Alaninamide
    2. Synonyms: D-ALANINAMIDE;(2R)-2-AMINOPROPANAMIDE;(2R)-2-Aminopropionamide;PropanaMide, 2-aMino-, (2R)-;(R)-2-AMinopropanaMide
    3. CAS NO:35320-22-0
    4. Molecular Formula: C3H8N2O
    5. Molecular Weight: 88.11
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 35320-22-0.mol
  • Chemical Properties

    1. Melting Point: 74-76 °C
    2. Boiling Point: 247.433 °C at 760 mmHg
    3. Flash Point: 103.444 °C
    4. Appearance: /
    5. Density: 1.063 g/cm3
    6. Vapor Pressure: 0.0257mmHg at 25°C
    7. Refractive Index: 1.467
    8. Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
    9. Solubility: N/A
    10. PKA: 15.99±0.50(Predicted)
    11. CAS DataBase Reference: D-Alaninamide(CAS DataBase Reference)
    12. NIST Chemistry Reference: D-Alaninamide(35320-22-0)
    13. EPA Substance Registry System: D-Alaninamide(35320-22-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 35320-22-0(Hazardous Substances Data)

35320-22-0 Usage

Uses

(R)-2-Aminopropanamide is a useful reagent for the synthesis of peptides.

Check Digit Verification of cas no

The CAS Registry Mumber 35320-22-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,3,2 and 0 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 35320-22:
(7*3)+(6*5)+(5*3)+(4*2)+(3*0)+(2*2)+(1*2)=80
80 % 10 = 0
So 35320-22-0 is a valid CAS Registry Number.
InChI:InChI=1/C3H8N2O/c1-2(4)3(5)6/h2H,4H2,1H3,(H2,5,6)/t2-/m1/s1

35320-22-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name (2R)-2-aminopropanamide

1.2 Other means of identification

Product number -
Other names H-D-Ala-NH2

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:35320-22-0 SDS

35320-22-0Relevant articles and documents

Mechanistic Insight into the Origin of Stereoselectivity in the Ribose-Mediated Strecker Synthesis of Alanine

Legnani, Luca,Darù, Andrea,Jones, Alexander X.,Blackmond, Donna G.

supporting information, p. 7852 - 7858 (2021/05/26)

Enantioenriched amino acids are produced in a hydrolytic kinetic resolution of racemic aminonitriles mediated by chiral pentose sugars. Experimental kinetic and spectroscopic results combined with DFT computational studies and microkinetic modeling help to identify the nature of the intermediate species and provide insight into the stereoselectivity of their hydrolysis in the prebiotically relevant ribose-alanine system. These studies support a synergistic role for sugars and amino acids in the emergence of homochirality in biological molecules.

2-(N-Benzyl-N-phenylsulfonamido)alkyl amide derivatives as γ-secretase inhibitors

Parker, Michael F.,Barten, Donna M.,Bergstrom, Carl P.,Bronson, Joanne J.,Corsa, Jason A.,Dee, Michael F.,Gai, Yonghua,Guss, Valerie L.,Higgins, Mendi A.,Keavy, Daniel J.,Loo, Alice,Mate, Robert A.,Marcin, Larry R.,McElhone, Katharine E.,Polson, Craig T.,Roberts, Susan B.,MacOr, John E.

, p. 6828 - 6831,4 (2020/09/02)

A series of (N-benzyl-N-phenylsulfonamido)alkyl amides were developed from classic and parallel synthesis strategies. Compounds with good in vitro and in vivo γ-secretase activity were identified and described.

Peptides having antiangiogenic activity

-

, (2008/06/13)

Peptides of formula (I) Xaa1-Xaa2-Xaa3-Xaa4-Xaa5-Xaa6-Xaa7-Xaa8-Xaa9-Xaa10-Xaa11??(I), are useful for inhibiting angiogenesis. Also disclosed are angiogenesis-inhibiting compositions and methods of inhibiting angiogenesis in a mammal.

N-alkylated peptides having antiangiogenic activity

-

, (2008/06/13)

N-Alkylated peptides of formula (I) Xaa1-Xaa2-Xaa3-Xaa4-Xaa5-Xaa6-Xaa7-Xaa8-Xaa9-Xaa10-Xaa11??(I), are useful for inhibiting angiogenesis. Also disclosed are angiogenesis-inhibiting compositions and methods of inhibiting angiogenesis in a mammal.

INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE

-

, (2008/06/13)

The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras.

6-position modified decapeptide LHRH antagonists

-

, (2008/06/13)

The present invention provides a class of decapeptide compounds which are potent antagonists of LHRH activity and which have the structure A1 -D2 -E3 -G4 -J5 -L6 -M7 -Q8 -R9 -T10. The compounds of the percent invention are characterized by having an Ω-amino-functionalized side chain on the D-aminoacyl residue at position 6. The Ω-amino group of this side chain is further derivatized by the attachment of an extending group which likewise has a terminal amino group which is capped by an acyl group.

N-terminus modified analogs of LHRH

-

, (2008/06/13)

Decapaptide and undecapaptides substituted on the N-terminal nitrogen atom by acyl groups which include furo-2-yl, isonicotinyl, nicotinyl, 2-, 3-, and 4-quinolinecarbonyl, shikimyl, dihydroshikimyl, and tetrahydrofur-2-oyl are potent antagonists of LHRH and are useful for suppressing the levels of sex hormones in mammals.

La pronase immobilisee sur poly(N-acryloylpiperidin-4-one): un catalyseur d'hydrolyse L-enantiospecifique des α-aminonitriles

Taillades, Jacques,Garrel, Laurence,Guillen, Franck,Collet, Helene,Commeyras, Auguste

, p. 119 - 127 (2007/10/02)

Pronase immobilized on poly(N-acryloylpiperidin-4-one) : a L-enantiospecific hydrolysis of α-aminonitriles with immobilized amidase. α-Aminonitriles are not substrates for pronase (an amidase) in the homogeneous phase but become substrates for pronase when it is immobilized on polymer matrix with ketonic sites (piperidin-4-one).In this paper we show that under low basic aqueous conditions (pH 10-11), the hydration of α-aminonitriles can be efficiently catalyzed by poly(N-acryloylpiperidin-4-one) crosslinked with 1,4-bis acryloylpiperazine (A(80:20)) in the presence of phosphate or borate buffers.These conditions comply with the hydrolysis of α-aminoamides by pronase immobilized on poly(N-acryloylpiperidin-4-one)crosslinked with 1,4-bis(acryloyl)piperazine (A(80:20/p).Thus, in a buffered borate solution at pH 10.5, α(DL)-aminonitrile is enantiospecifically hydrolyzed into α(D)-aminoamide and α(L)-amino acid. Key words: α-aminonitriles / α amino acids / L-enantiospecific hydrolysis / polymer-supported catalysis / nitrilasic activity

Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation

-

, (2008/06/13)

The invention provides new compounds of formula (I) STR1 wherein n is an integer of 1 to 4; each of R and R1, which may be the same or different, is hydrogen, halogen, trifluoromethyl or C1 -C4 alkoxy; R2 is hydrogen or C1 -C4 alkyl; and a pharmaceutically acceptable salts thereof; and wherein when, at the same time, R is hydrogen, R1 is hydrogen or halogen and n is one, then R2 is other than hydrogen or methyl; and of formula (IA) STR2 wherein R3 is halogen, and a pharmaceutical acceptable salt thereof, which are active on the central nervous system (CNS) and can be used in therapy as anti-epileptics, anti-Parkinson, neuroprotective, antidepressant, anti-spastic and hypnotic agents.

LHRH analogs

-

, (2008/06/13)

The present invention relates to novel ""pseudo"" nonapeptide and decapeptide derivatives of LHRH. More particularly the present invention relates to derivatives of LHRH wherein the nitrogen atom of at least one of the amide bonds has been alkylated.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 35320-22-0